← Eichor
Study identifier: NCT06633575 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Profile and Regulatory Network of Exercise in Improving Metabolic Phenotypes of Patients With Prediabetes

Condition: Prediabetes  ·  Sponsor: Shanghai Zhongshan Hospital

PhaseNA
Planned participants40
Who can joinAll sexes, 19 Years to 55 Years
Healthy volunteersNo

About this study

This study is a single-arm, self-control, single-center study to investigate the molecular mechanism under exercise improving metabolism of patients with prediabetes. 40 overweight/obese patients with prediabetes will be recruited in this study and instructed to participate in an 8-week exercise program. We aim to investigate 1) the changes of clinical phenotypes such as body weight, body fat, laboratory values, and resting energy expenditure before and after exercise 2) the changes of peripheral blood mononuclear cell by single cell sequencing 3) search for potential biomarkers of exercise in improving metabolism through multi-omics integrated analysis of single-cell transcriptome, phenomics, metabolomics, etc.

This description comes directly from the study's public registry record.

Talk to the study team

Ying Chen  ·  86+19542806360  ·  chen.ying4@zs-hospital.sh.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Zhongshan Hospital, Fudan UniversityShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06633575